Novel Human Androgen Receptor Alternative Splice Variants As Biomarkers and Therapeutic Targets
The present invention relates to novel androgen receptor splice variants (AR3, AR4, AR4b, AR5 and AR8) and variants and fragments thereof which have a role in the progression of androgen independent prostate cancer. The invention further relates to compositions and methods which can be used to identify and treat prostate cancer based on these novel androgen receptor splice variants, as well as methods for screening agents which modulate the activity and/or expression of the androgen receptor splice variants. Vectors, host cells and recombinant methods for producing the same and transgenic animals are also provided.
QIU YUN [US]; GUO ZHIYONG [US]; YANG XI [US]
Type of Offer:
« More Biotech Patents